PRESS RELEASE published on 10/14/2025 at 07:00, 8 months 12 days ago Inside Information / Other news releases Innate Pharma to host analyst and investor event on Lacutamab on October 28, 2025. Event includes clinical perspectives, market outlook, and updates on Phase 3 trial and regulatory pathway for lacutamab Phase 3 Trial Investor Event Regulatory Pathway Innate Pharma Lacutamab
PRESS RELEASE published on 10/14/2025 at 07:00, 8 months 12 days ago Informations privilégiées / Autres communiqués Innate Pharma organise un événement analystes et investisseurs dédié à Lacutamab le 28 octobre 2025, mettant en lumière les perspectives cliniques et commerciales du produit Investisseurs Événement Innate Pharma Analystes Lacutamab
PRESS RELEASE published on 09/22/2025 at 13:41, 9 months 4 days ago Informations privilégiées / Communiqué sur comptes, résultats
PRESS RELEASE published on 09/17/2025 at 07:00, 9 months 9 days ago Informations privilégiées / Communiqué sur comptes, résultats
BRIEF published on 09/10/2025 at 10:35, 9 months 16 days ago Innate Pharma Annonce une Conférence Téléphonique pour ses Résultats Semestriels 2025 Résultats Financiers Immunothérapie Conférence Téléphonique Partenariats Biopharmaceutiques Innate Pharma
BRIEF published on 09/10/2025 at 10:35, 9 months 16 days ago Innate Pharma Announces 2025 Half-Year Results Conference Call Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
PRESS RELEASE published on 09/10/2025 at 10:30, 9 months 16 days ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique pour présenter ses résultats financiers et l’avancée de son portefeuille au premier semestre 2025 Résultats Financiers Conférence Téléphonique Portefeuille Innate Pharma Biotechnologies
PRESS RELEASE published on 09/10/2025 at 10:30, 9 months 16 days ago Inside Information / Other news releases Innate Pharma schedules conference call and webcast for first half 2025 financial results and business update. Details for participation available on the company's website Financial Results Conference Call Business Update Webcast Innate Pharma
BRIEF published on 09/02/2025 at 07:05, 9 months 24 days ago Innate Pharma : Mise à jour sur le capital et les droits de vote Droits De Vote Actions AMF Immobilier Innate Pharma
BRIEF published on 09/02/2025 at 07:05, 9 months 24 days ago Innate Pharma: Update on capital and voting rights Voting Rights Real Estate Actions AMF Innate Pharma
Published on 06/26/2026 at 14:05, 6 hours 20 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 6 hours 25 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 7 hours 25 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 7 hours 40 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 19:50, 35 minutes ago Name Change Completed for C Capital's Swiss Listed Entity, Ticker Symbol CCAP Goes Live
Published on 06/26/2026 at 19:10, 1 hour 15 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/26/2026 at 18:04, 2 hours 21 minutes ago Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Published on 06/26/2026 at 18:00, 2 hours 25 minutes ago PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.
Published on 06/26/2026 at 18:00, 2 hours 25 minutes ago VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
